Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Patients with severe aortic stenosis and reduced left ventricular systolic function may do better with transcatheter implantation of a prosthetic aortic valve than…
NEW YORK (Reuters Health) – Women with breast cancer treated with anthracycline-taxane based regimens are more likely to become amenorrheic than women treated with just anthracyclines or conventional…
NEW YORK (Reuters Health) – Very elderly patients, perhaps up to 100 years old, with acute ischemic stroke benefit from timely thrombolytic therapy to the same degree as…
NEW YORK (Reuters Health) – Results of in vitro testing indicate that silver impregnation of urinary catheters has little effect on bacterial adherence, reinforcing findings from clinical studies…
NEW YORK (Reuters Health) – Combined multichannel intraluminal impedance monitoring (MII) and pH monitoring in the esophagus detects gastroesophageal reflux (GER) in children more accurately than pH monitoring…
NEW YORK (Reuters Health) – Patients who develop acute renal failure (ARF) after undergoing coronary artery bypass grafting have a poorer prognosis if the condition doesn’t resolve within…
As a physician, has a frivolous lawsuit been brought against you?Have you been a victim of sham peer review?Have you been accused of disruptive physician behavior?We can help…
NEW YORK (Reuters Health) – Chronic Chagas disease in the elderly doubles their risk of dying from a stroke, and the risk is increased further in those with…
NEW YORK (Reuters Health) – After first-line treatment with bevacizumab plus interferon-alpha2a, subsequent therapy with tyrosine kinase inhibitors (TKIs) improves survival in patients with metastatic renal cell carcinoma,…
NEW YORK (Reuters Health) – The patency of saphenous veins used for coronary artery bypass grafting is better in the 3 months after the operation when patients are…
